Evidence map›Paper›PMID 36135003›Full record

ArticleBioengineering (Basel, Switzerland)2022

MEF: Multidimensional Examination Framework for Prioritization of COVID-19 Severe Patients and Promote Precision Medicine Based on Hybrid Multi-Criteria Decision-Making Approaches.

Karrar Hameed Abdulkareem, Mohammed Nasser Al-Mhiqani, Ahmed M Dinar, Mazin Abed Mohammed, Mustafa Jawad Al-Imari, Alaa S Al-Waisy, Abed Saif Alghawli, Mohammed A A Al-Qaness

Open access · goldAbstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Event-Specific Transmission Forecasting of SARS-CoV-2 in a Mixed-Mode Ventilated Office Room Using an ANN.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 5 countries.

Karrar Hameed AbdulkareemCollege of Agriculture, Al-Muthanna University, Samawah 66001, Iraq.ORCID 0000-0001-7302-2049
Mohammed Nasser Al-MhiqaniCenter for Advanced Computing Technology, Faculty of Information and Communication Technology, Universiti Teknikal Malaysia Melaka, Malacca 75300, Malaysia.ORCID 0000-0002-8802-487X
Ahmed M DinarComputer Engineering Department, University of Technology- Iraq, Baghdad 19006, Iraq.ORCID 0000-0002-9082-0875
Mazin Abed MohammedCollege of Computer Science and Information Technology, University of Anbar, Anbar 31001, Iraq.ORCID 0000-0001-9030-8102
Mustafa Jawad Al-ImariDepartment of Medical Laboratory Techniques, Al-Mustaqbal University College, Hillah 51001, Iraq.
Alaa S Al-WaisyComputer Technologies Engineering Department, Information Technology Collage, Imam Ja'afar Al-Sadiq University, Baghdad 10064, Iraq.ORCID 0000-0001-7544-2709
Abed Saif AlghawliComputer Science Department, College of Sciences and Humanities, Prince Sattam Bin Abdulaziz University, Aflaj 16278, Saudi Arabia.ORCID 0000-0002-6586-2141
Mohammed A A Al-QanessCollege of Physics and Electronic Information Engineering, Zhejiang Normal University, Jinhua 321004, China.ORCID 0000-0002-6956-7641
Alsalam University College · IQImam Ja’afar Al-Sadiq UniversityPrince Sattam Bin Abdulaziz University · SATechnical University of Malaysia Malacca · MYUniversity of Anbar · IQUniversity of Kerbala · IQUniversity of Technology - Iraq · IQZhejiang Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Effective prioritization plays critical roles in precision medicine. Healthcare decisions are complex, involving trade-offs among numerous frequently contradictory priorities. Considering the numerous difficulties associated with COVID-19, approaches that could triage COVID-19 patients may help in prioritizing treatment and provide precise medicine for those who are at risk of serious disease. Prioritizing a patient with COVID-19 depends on a variety of examination criteria, but due to the large number of these biomarkers, it may be hard for medical practitioners and emergency systems to decide which cases should be given priority for treatment. The aim of this paper is to propose a Multidimensional Examination Framework (MEF) for the prioritization of COVID-19 severe patients on the basis of combined multi-criteria decision-making (MCDM) methods. In contrast to the existing literature, the MEF has not considered only a single dimension of the examination factors; instead, the proposed framework included different multidimensional examination criteria such as demographic, laboratory findings, vital signs, symptoms, and chronic conditions. A real dataset that consists of data from 78 patients with different examination criteria was used as a base in the construction of Multidimensional Evaluation Matrix (MEM). The proposed framework employs the CRITIC (CRiteria Importance Through Intercriteria Correlation) method to identify objective weights and importance for multidimensional examination criteria. Furthermore, the VIKOR (VIekriterijumsko KOmpromisno Rangiranje) method is utilized to prioritize COVID-19 severe patients. The results based on the CRITIC method showed that the most important examination criterion for prioritization is COVID-19 patients with heart disease, followed by cough and nasal congestion symptoms. Moreover, the VIKOR method showed that Patients 8, 3, 9, 59, and 1 are the most urgent cases that required the highest priority among the other 78 patients. Finally, the proposed framework can be used by medical organizations to prioritize the most critical COVID-19 patient that has multidimensional examination criteria and to promptly give appropriate care for more precise medicine.

Indexed as

COVID-19CRITIChybrid multi-criteria decision-makingMultidimensional Examination Frameworkprecision medicineprioritizationVIKOR

Identifiers

PMID36135003
PMCPMC9495842
OpenAlexW4295207020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.